Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms.

J Allergy Clin Immunol

Department of Pathophysiology and Allergy Research, Medical University of Vienna, Waehringer Guertel, Vienna, Austria; NRC Institute of Immunology FMBA of Russia, Moscow, Russia; Laboratory for Immunopathology, Department of Clinical Immunology and Allergy, Sechenov First Moscow State Medical University, Moscow, Russia. Electronic address:

Published: March 2019

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411133PMC
http://dx.doi.org/10.1016/j.jaci.2018.11.011DOI Listing

Publication Analysis

Top Keywords

vaccination nonallergic
4
nonallergic individuals
4
individuals recombinant
4
recombinant hypoallergenic
4
hypoallergenic fragments
4
fragments birch
4
birch pollen
4
pollen allergen
4
allergen bet
4
bet safety
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!